September 24, 2019 Does amount matter when it comes to a biotech IPO? Biontech and ADC Therapeutics are both heading towards substantial flotations, but it is hard to find evidence that bigger does better.
June 05, 2019 Asco 2019 event analyser – low-key meeting belies some huge stock moves Mirati Therapeutics nearly stole the show at Asco despite not actually presenting – a fact that illustrates how low on meaningful data this year's conference was.
April 10, 2018 Where is the IPO class of 2014-15 now? A golden age for biotech flotations yielded some spectacular blow-ups, but also saw several groups reward investors with premium-priced takeovers.